Attached files
| file | filename |
|---|---|
| 8-K/A - 8-K/A - Mallinckrodt plc | mnk8-ka051614.htm |
| EX-99.2 - EXHIBIT 99.2 - Mallinckrodt plc | mnkexhibit992proforma.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
(1) | Registration Statement (Form S-8 No. 333-189716 ) pertaining to the Employee Matters Agreement Equity Awards plan of Mallinckrodt plc, |
(2) | Registration Statement (Form S-8 No. 333-189712) pertaining to the Mallinckrodt Pharmaceuticals Stock and Incentive Plan of Mallinckrodt plc, and |
(3) | Registration Statement (Form S-8 No. 333-189712) pertaining to the Mallinckrodt Pharmaceuticals Employee Stock Purchase Plan and Mallinckrodt Pharmaceuticals Savings Related Share Plan of Mallinckrodt plc; |
of our report dated February 28, 2014, with respect to the financial statements and schedule of Cadence Pharmaceuticals, Inc. included in Cadence Pharmaceuticals, Inc. Annual Report (Form 10-K) for the year ended December 31, 2013 incorporated by reference in this Form 8-K/A of Mallinckrodt plc.
/s/ Ernst & Young LLP
San Diego, California
May 16, 2014